Evaluating the Sapien® XT Valve in Native Right Ventricular Outflow Tracts After Tetralogy of Fallot Repair: Mid- and Long-Term Results
Open Access
- 21 January 2025
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (1) , 362-374
Abstract
Although the long-term outcomes of the surgical grafts are well defined and reported, the data regarding the mid-and long-term results of the balloon-expandable percutaneous valves in the native right ventricular outflow tract (RVOT) is limited. We retrospectively evaluated 42 patients who underwent PPVI (Sapien® XT valve) to native RVOT due to severe pulmonary regurgitation (PR) and/or moderate to severe pulmonary stenosis (PS) between August 2015 and November 2020. The median patient age at the time of PPVI was 13.4 years (6.1–36.5 years). The median body weight of the patients was 42 kg (15–110 kg). The rate of patients who were followed up without the need for percutaneous or surgical intervention was 97.4% at the end of year 1, 89.3% at the end of year 3, and 85.8% at the end of year 5. At the end of year 6, the proportion of patients requiring no procedure remained constant, with year 5 at 85.8%, but decreased to 70.2% at the end of year 7. Although the early results are very encouraging, it is seen that PPVI in patients with RVOT in the long term brings some problems. The most important of these is tricuspid valve problems, which were not considered before the procedure. Patients requiring reintervention due to pulmonary regurgitation show similar characteristics to surgical valves’ long-term results.Keywords
Funding Information
- University of Health Sciences
This publication has 31 references indexed in Scilit:
- Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive featuresArchives of Cardiovascular Diseases, 2023
- Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5‐year follow‐up in a French RegistryCatheterization and Cardiovascular Interventions, 2021
- SAPIEN S3 valve deployment in the pulmonary position using the gore DrySeal sheath to protect the tricuspid valveCatheterization and Cardiovascular Interventions, 2020
- Long-term Outcomes of Tetralogy of FallotJAMA Cardiology, 2019
- Initial results from the off‐label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi‐institutional experienceCatheterization and Cardiovascular Interventions, 2018
- SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre‐stenting”: A multi‐institutional experienceCatheterization and Cardiovascular Interventions, 2018
- Functional Tricuspid RegurgitationJACC, 2015
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary PositionJACC, 2011
- Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards Sapien transcatheter heart valveCatheterization and Cardiovascular Interventions, 2011